Program
Please note that this meeting will take place as an in-person event in Toronto and will not live-stream content for virtual participation.
MONDAY, JUNE 21
- Welcome and Keynote lecture
- Plenary Session 1: Harnessing Cancer Evolution for Drug Discovery—Working Group Session
- Poster Session A and Opening Reception
TUESDAY, JUNE 22
- Continental Breakfast
- Plenary Session 2: AI and Computational Prediction of Cancer Evolution
- Plenary Session 3: Somatic Evolution in Normal Tissues and Aging
- Proffered Talk Session
- Plenary Session 4: Premalignant Disease & Cancer Initiation
- Plenary Session 5: Low Disease Burden/MRD/Early Interception
- Poster Session B / Reception
WEDNESDAY, JUNE 23
- Continental Breakfast
- Plenary Session 6: Metastatic Cascade and Divergent Evolution
- Plenary Session 7: Tumor–Host Crosstalk/Co Evolution
- Plenary Session 8: Treatment Resistance and Evolution Under Therapy
- Closing Remarks
REGISTRATION
3-9 p.m.
WELCOME AND Keynote Lectures
5-6:30 p.m.
- 5:30 p.m. | Welcome by cochairs and introduction of keynote speaker
- 5:35 p.m. | Opening Keynote Lecture
Laura D. Wood, Johns Hopkins University, Baltimore, Maryland
Plenary Session 1: Harnessing Cancer Evolution for Drug Discovery—Working Group Session6:
6:10-7:30 p.m.
Session organized by the Cancer Evolution Working Group
Session Chair: Trevor A. Graham, The Institute of Cancer Research, London, United Kingdom
- Louis M. Weiner, Georgetown University, Washington, DC
- Christine A. Iacobuzio-Donahue, Memorial Sloan Kettering Cancer Center, New York, New York
- Trevor A. Graham, Institute of Cancer Research, London, United Kingdom
Short talk selected from proffered abstract
Poster Session A and Opening Reception
7:30-9 p.m
Continental Breakfast
7-8 a.m.
Plenary Session 2: AI and Computational Prediction of Cancer Evolution
8-9:40 a.m.
- Systematic identification of key metabolic modifiers of lung precancerous evolution and its potential reversal
Eytan M. Ruppin, National Cancer Institute, Bethesda, Maryland - Franziska Michor, Dana-Farber Cancer Institute, Boston, Massachusetts
Break
9:40 a.m.- 10 a.m.
Plenary Session 3: Somatic Evolution in Normal Tissues and Aging
10 a.m.-11:40 a.m.
Proffered talk session
11:40 a.m.-12:30 p.m.
Lunch on own
12:30 p.m.-2 p.m.
Plenary Session 4: Premalignant Disease and Cancer Initiation
2 p.m.-3:40 p.m.
- Kathleen (Kit) Curtius, University of California San Diego, La Jolla, California
- Measuring and managing the evolution and ecology of neoplastic progression
Carlo Maley, Arizona State University, Tempe, Arizona
Additional speakers to be announced
Short talks selected from proffered abstracts
Break
3:40 – 4 p.m.
Plenary Session 5: The Aging-Inflammation-Cancer Continuum
4-6 p.m.
- Stephanie Spranger, Massachusetts Institute of Technology, Cambridge, Massachusetts
- Scott Kopetz, The University of Texas MD Anderson Cancer Center, Houston, Texas
Additional speakers to be announced
Short talks selected from proffered abstracts
Poster Session B And Reception
6-7:30 p.m.
Continental Breakfast
7-8 a.m.
Plenary Session 6: Metastatic Cascade and Divergent Evolution
8-9:20 a.m.
- Quantification of metastatic capacity across cancer types
Kamila Naxerova, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts - Mechanisms of plasticity in colorectal cancer metastasis
Karuna Ganesh, Memorial Sloan Kettering Cancer Center, New York, New York
Break
9:20-11:45 a.m.
Plenary Session 7:Tumor–Host Crosstalk/Co Evolution
9:45-11:30 a.m.
- Karin de Visser, Netherlands Cancer Institute, Amsterdam, Netherlands
Additional speakers to be announced
Break
11:30 -11:45 a.m
Keynote LEcture
11:45 a.m.-12:20 p.m
- Tyler E. Jacks, Massachusetts Institute of Technology, Cambridge, Massachusetts
Plenary Session 8: Treatment Resistance and Evolution Under Therapy
12:20-1:40 p.m.
- Cristina Puig-Saus, University of California Los Angeles, Los Angeles, California
- Adam C. Palmer, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Closing Remarks and Departure
1:40 p.m.